Skip to main content
Premium Trial:

Request an Annual Quote

Dolomite to Collaborate on EU-funded Microfluidics Tech for Stem Cells

NEW YORK (GenomeWeb News) – UK-based microfluidics developer Dolomite said today that it will collaborate with the Danish firms Bioneer and OptoRobotix in a European Union-funded effort to develop a new stem cell handling device.

The consortium has received €820,100 ($1.1 million) from the EU's Eurostars program to fund the two-year project, which aims to develop a microfluidic tool that could be used in molecular biology, biotechnology, and pharmaceutical applications.

The OPTISORT platform will be a sorting and analysis tool that uses optical and droplet technologies for sorting fragile mammalian cells. It will enable stem cell biology and mammalian cell-based protein manufacturing, which the company said are both fast-developing fields.

OptoRobotix develops flow cytometers with cell sorting capabilities. Bioneer, a subsidiary of the Technical University of Denmark, provides access to tools to facilitate therapeutic, cellular, and molecular biology projects.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.